APC/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
  • 30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
    C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
See APC/Cyanine7 spectral data
Cat # Size Price Quantity Avail. Save
103115 25 µg 68,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103116 100 µg 152,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6 and Western blotting7. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
Product Citations
  1. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  2. Ayaub E,et al. 2017. Sci Rep.. 10.1038/s41598-017-13511-z. PubMed
  3. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  4. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  5. Armaka M, et al. 2018. Nat Commun. 9:618. PubMed
  6. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  7. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  8. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  9. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  10. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  11. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  12. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  13. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  14. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  15. Wakabayashi T et al. 2018. Cell stem cell. 22(3):384-397 . PubMed
  16. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  17. Selvaraj UM et al. 2018. Endocrinology. 159(11):3848-3859 . PubMed
  18. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  19. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  20. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  21. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  22. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  23. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  24. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  25. Commerford CD et al. 2018. Cell reports. . PubMed
  26. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  27. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  28. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  29. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  30. Jiang P, et al. 2018. Nat Med. 24:1550. PubMed
  31. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  32. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  33. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  34. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  35. Evans R, et al. 2019. Cell Rep. 27:1967. PubMed
  36. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  37. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  38. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  39. Page N, et al. 2018. Immunity. 48:937. PubMed
  40. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  41. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  42. Kaiser T, et al. 2019. Eneuro. 6. PubMed
  43. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  44. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  45. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  46. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  47. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  48. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  49. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  50. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  51. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  52. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  53. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  54. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  55. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  56. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  57. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  58. Martin A, et al. 2018. Oncotarget. 9:28364. PubMed
  59. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  60. Ning F, et al. 2019. J Exp Med. 216:1396. PubMed
  61. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  62. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  63. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  64. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  65. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  66. Wiley CD, et al. 2019. JCI Insight. 4:e130056. PubMed
  67. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  68. Pluchino N, et al. 2020. J Cell Mol Med. 24:2464. PubMed
  69. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  70. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  71. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  72. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  73. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  74. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  75. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  76. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  77. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  78. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  79. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  80. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  81. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  82. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  83. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  84. Gago-Lopez N, et al. 2019. EMBO Mol Med. 11:e10697. PubMed
  85. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  86. Forte E, et al. 2020. Cell Rep. 30:3149. PubMed
  87. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  88. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  89. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  90. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  91. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  92. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  93. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  94. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  95. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  96. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  97. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  98. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  99. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  100. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  101. Hohsfield LA, et al. 2020. J Neuroinflammation. 0.902083333. PubMed
  102. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  103. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  104. Michaelis KA, et al. 2019. Brain Behav Immun. 82:338. PubMed
  105. Krasteva G, et al. 2011. Proc Natl Acad Sci U S A. 108:9478. PubMed
  106. Draper D, et al. 2012. J Immunol. 188:5327. PubMed
  107. Haka A, et al. 2012. PLoS One. 7:e44823. PubMed
  108. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  109. Seeling M, et al. 2013. Proc Natl Acad Sci U S A. 110:10729. PubMed
  110. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  111. Lux A, et al. 2014. Cell Rep. 10:236. PubMed
  112. Mantia-Smaldone G, et al. 2014. Gynecol Oncol. 133:584. PubMed
  113. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  114. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  115. Hoeksema M, et al. 2015. J Immunol. 194:3909. PubMed
  116. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  117. Gierut J, et al. 2015. Stem Cell Res. 15: 165-171. PubMed
  118. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  119. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
  120. Veremeyko T, et al. 2012. J Vis Exp. 65: 4097. PubMed
  121. Martina M, et al. 2014. J Vis Exp. 87: 51192. PubMed
  122. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  123. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  124. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  125. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  126. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  127. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  128. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  129. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  130. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  131. Klein S, et al. 2016. J Cell Sci. 129: 2573 - 2585. PubMed
  132. Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
  133. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
  134. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  135. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  136. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  137. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  138. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  139. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  140. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
  141. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  142. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  143. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  144. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  145. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  146. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  147. Zhang X, et al. 2020. Elife. 9:00. PubMed
  148. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  149. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  150. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  151. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  152. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  153. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  154. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  155. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  156. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  157. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  158. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  159. Ou YC, et al. 2020. ACS Nano. 1.035416667. PubMed
  160. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  161. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  162. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  163. Naito H, et al. 2020. Nature Protocols. 15(3):1066-1081. PubMed
  164. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  165. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  166. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  167. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  168. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  169. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  170. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  171. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  172. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  173. Ma Y, et al. 2021. Developmental Cell. 56(4):478-493.e11. PubMed
  174. Wang LT, et al. 2021. STAR Protocols. 2(1):100337. PubMed
  175. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  176. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  177. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  178. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  179. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  180. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  181. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  182. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  183. Marangoni F, et al. 2021. Cell. . PubMed
RRID
AB_312980 (BioLegend Cat. No. 103115)
AB_312981 (BioLegend Cat. No. 103116)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 01/30/2019

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account